INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, cilt.13, sa.4, ss.497-504, 2003 (SCI-Expanded)
The aim of this study is to identify the impact of various prognostic factors on survival in patients with recurrent carcinoma of the uterine cervix. Fifty-two patients who were treated with platinum-based chemotherapy for recurrent or metastatic disease were retrospectively evaluated. Twenty-seven patients (90%) had received pelvic radiation as primary treatment.